Search for: "ASTRAZENECA UK LIMITED"
Results 41 - 60
of 73
Sort by Relevance
|
Sort by Date
15 Jul 2011, 5:38 am
AstraZeneca, however, argued that this was a simple process claim and that as such, it was not limited to the manufacture of specific products but extended to the use of the claimed process to make any product. [read post]
11 May 2011, 4:54 am
General UNCTAD: Bundle of opportunities to improve medicines access in LDCs (IP Watch) Australia: Why IP professionals must take ‘gene patent’ opponents seriously (Patentology) Australia: FCA finds fatal flaw in Plant Breeders Rights Act: Elders Rural Services Australia Limited v Registrar of Plant Breeder’s Rights (Patentology) (ipwars) Finland: Decision on parallel import of pharmaceuticals (Class 46) Italy: Again on MA filing as a preparatory act of marketing –… [read post]
8 Dec 2010, 2:20 am
Allergan, Inc (Docket Report) Products Enbrel (Etanercept) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Fabrazyme (Alpha-galactosidase) – US: Statements by KEI and others on NIH rejection of Fabrazyme march-in request (KEI) Intuniv (Guanfacine) – US: Impax confirms patent challenge relating to Intuniv (GenericsWeb) Lovenox (Enoxaparin) – US: Momenta sues Teva over claims relating to ways of manufacturing and analysing structure… [read post]
17 Nov 2010, 1:48 am
(Patent Baristas) A round up of international events – Access and Benefit Sharing Protocol; review of Para 6 system; concerns with ACTA’s compatibility with TRIPS(Spicy IP) Compromise UN protocol treaty against biopiracy adopted in Japan (IP Watch) (Innovation Law Blog) TRIPS Council discusses efficacy of ACTA, public health amendment (IP Watch) Altering genes in crops (IP Osgoode) Asia Pacific Pharmas moving away from generics (GenericsWeb) Belgium Commercial Court: No faultless… [read post]
14 Jul 2010, 6:47 pm
Stallergenes (EPLAW) UK: Discovery of documents: is there a real benefit? [read post]
17 Feb 2010, 8:00 am
Aquatron Inc. and Aqua Group LLC (patent infringement) 1/7: AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited and AstraZeneca AB v. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Colmetec (Olmesartan medoxomil, hydrochlorothiazide) – France: Cour d’appel de Paris say ‘non’ to olmesartan medoxomil and hydrochlorothiazide combination SPC: Daiichi Sankyo Company v INPI (SPC Blog) Crestor (Rosuvastatin) – US: Generic drug makers, Teva, Apotex and others seek to remove AstraZeneca LP as party in Crestor suit (Patent Docs) Differin (Adapalene) – US: Patent infringement complaint following a Paragraph IV certification -… [read post]
13 Mar 2009, 2:00 am
(GenericsWeb) India’s Human Genome Bill (Spicy IP) Indian drugmakers push into US generics market (GenericsWeb) Uganda: Indian generic manufacturers concerned anti-counterfeit legislation may threaten market in Uganda and surrounding territories (Afro-IP) UK: Court of Appeal admonishes counsel for dilatory actions involved in parallel British and EPO proceedings: Eli Lilly & Co v Human Genome Sciences (Hal Wegner) (PatLit) US: President Obama to lift stem cell… [read post]
27 Feb 2009, 5:00 am
USA, Inc (Orange Book Blog) (FDA Law Blog) (Patent Baristas) (Law360) (Patent Docs) (Patent Prospector) (Patently-O) (GenericsWeb) (Hal Wegner) Cipramil (Citalopram) – UK: House of Lords upholds second-generation patent that had been invalidated at first instance for insufficiency: Generics (UK) Limited and others v H Lundbeck A/S (Managing Intellectual Property)(IPKat) US: Congressman Waxman tells GPhA meeting that Hatch-Waxman model will work for follow-on… [read post]
9 Nov 2008, 11:48 pm
Boston Globe AHN Pharmalot Over the Limit Market Watch About CTV Canada The Heart.org Medpage Today Cardiosource RTT News Metro UK Short News.com Current World News EurekAlert Canada News Wire The Wall Street Journal 0Digg me [read post]
5 Sep 2008, 11:01 pm
: (Excess Copyright), (Michael Geist), Opinion and analysis of C-61: (Michael Geist), (Michael Geist), (Michael Geist), (Michael Geist), (Michael Geist), (Michael Geist), 61 reforms to C-61: (Day 50: Education harms – lessons contain limited definition of students – Michael Geist), (Day 51: Education internet exception is unnecessary – Michael Geist), (Day 52: Education internet exception is harmful – Michael Geist), (Day 53: Education internet… [read post]
29 Aug 2008, 1:25 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
24 Aug 2008, 10:16 am
Current members of the TMPDF are ARM Ltd; AstraZeneca plc; Babcock International Ltd; BAE Systems plc; BP p.l.c.; British Telecommunications plc; British-American Tobacco Co Ltd; BTG plc; Delphi Corp.; Dow Corning Ltd; Dyson Technology Ltd; ExxonMobil Chemical Ltd; Ford of Europe; Fujitsu Services Ltd; G E Healthcare; GKN plc; GlaxoSmithKline plc; Hewlett-Packard Ltd; IBM UK Ltd; Infineum UK Ltd; Kodak Ltd; Merck Sharp & Dohme Ltd; Microsoft Ltd; Nestle UK… [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper… [read post]
9 Aug 2008, 1:50 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its… [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its application… [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist concerning the… [read post]
5 Jul 2008, 11:05 am
interview: (IP tango) Events 7 July: PLI briefing webcast ‘Life after Quanta v LGE: What every patent lawyer needs to know’: (PLI), 7-15 July/16-18 July: 2nd Transatlantic IP summer academy, modules one and two – Alicante/Milan: (IPKat), 9 July 2008: ALI & ABA webcast ‘Quanta v LG: What you should know’: (Patent Docs), 11 July: CIPA moot to improve participants’ understanding of procedures of EPO Technical Boards of Appeal… [read post]
